APP and Alzheimer disease: Mouse AD models were, either non-transgenic [35,36], where mice’s brains were injected with a high concentration of Aβ1-42, or transgenic, most frequently used were the APP/PS1 double transgenic mice [11,38,39,40,41,42,43,44,45,46,47].